Global Cannabis-based Medicines Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15126431 | Publishing Date : 27-Jan-2020 | No. of pages : 94
Detailed TOC of Global Cannabis-based Medicines Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cannabis-based Medicines Revenue
1.4 Market Analysis by Type
1.4.1 Global Cannabis-based Medicines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CBD (Cannabidiol) Based
1.4.3 THC (Tetrahydrocannabinol) Based
1.4.4 Others
1.5 Market by Application
1.5.1 Global Cannabis-based Medicines Market Share by Application: 2020 VS 2026
1.5.2 Oral Solution
1.5.3 Tablets
1.5.4 Patches
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Cannabis-based Medicines Market Perspective (2015-2026)
2.2 Cannabis-based Medicines Growth Trends by Regions
2.2.1 Cannabis-based Medicines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cannabis-based Medicines Historic Market Share by Regions (2015-2020)
2.2.3 Cannabis-based Medicines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cannabis-based Medicines Market Growth Strategy
2.3.6 Primary Interviews with Key Cannabis-based Medicines Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cannabis-based Medicines Players by Market Size
3.1.1 Global Top Cannabis-based Medicines Players by Revenue (2015-2020)
3.1.2 Global Cannabis-based Medicines Revenue Market Share by Players (2015-2020)
3.1.3 Global Cannabis-based Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cannabis-based Medicines Market Concentration Ratio
3.2.1 Global Cannabis-based Medicines Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cannabis-based Medicines Revenue in 2019
3.3 Cannabis-based Medicines Key Players Head office and Area Served
3.4 Key Players Cannabis-based Medicines Product Solution and Service
3.5 Date of Enter into Cannabis-based Medicines Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Cannabis-based Medicines Historic Market Size by Type (2015-2020)
4.2 Global Cannabis-based Medicines Forecasted Market Size by Type (2021-2026)
5 Cannabis-based Medicines Breakdown Data by Application (2015-2026)
5.1 Global Cannabis-based Medicines Market Size by Application (2015-2020)
5.2 Global Cannabis-based Medicines Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cannabis-based Medicines Market Size (2015-2020)
6.2 Cannabis-based Medicines Key Players in North America (2019-2020)
6.3 North America Cannabis-based Medicines Market Size by Type (2015-2020)
6.4 North America Cannabis-based Medicines Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cannabis-based Medicines Market Size (2015-2020)
7.2 Cannabis-based Medicines Key Players in Europe (2019-2020)
7.3 Europe Cannabis-based Medicines Market Size by Type (2015-2020)
7.4 Europe Cannabis-based Medicines Market Size by Application (2015-2020)
8 China
8.1 China Cannabis-based Medicines Market Size (2015-2020)
8.2 Cannabis-based Medicines Key Players in China (2019-2020)
8.3 China Cannabis-based Medicines Market Size by Type (2015-2020)
8.4 China Cannabis-based Medicines Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cannabis-based Medicines Market Size (2015-2020)
9.2 Cannabis-based Medicines Key Players in Japan (2019-2020)
9.3 Japan Cannabis-based Medicines Market Size by Type (2015-2020)
9.4 Japan Cannabis-based Medicines Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cannabis-based Medicines Market Size (2015-2020)
10.2 Cannabis-based Medicines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cannabis-based Medicines Market Size by Type (2015-2020)
10.4 Southeast Asia Cannabis-based Medicines Market Size by Application (2015-2020)
11 India
11.1 India Cannabis-based Medicines Market Size (2015-2020)
11.2 Cannabis-based Medicines Key Players in India (2019-2020)
11.3 India Cannabis-based Medicines Market Size by Type (2015-2020)
11.4 India Cannabis-based Medicines Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cannabis-based Medicines Market Size (2015-2020)
12.2 Cannabis-based Medicines Key Players in Central & South America (2019-2020)
12.3 Central & South America Cannabis-based Medicines Market Size by Type (2015-2020)
12.4 Central & South America Cannabis-based Medicines Market Size by Application (2015-2020)
13Key Players Profiles
13.1 GW Pharmaceuticals plc
13.1.1 GW Pharmaceuticals plc Company Details
13.1.2 GW Pharmaceuticals plc Business Overview and Its Total Revenue
13.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Introduction
13.1.4 GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2015-2020))
13.1.5 GW Pharmaceuticals plc Recent Development
13.2 INSYS Therapeutics
13.2.1 INSYS Therapeutics Company Details
13.2.2 INSYS Therapeutics Business Overview and Its Total Revenue
13.2.3 INSYS Therapeutics Cannabis-based Medicines Introduction
13.2.4 INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2015-2020)
13.2.5 INSYS Therapeutics Recent Development
13.3 Aequus Pharmaceuticals
13.3.1 Aequus Pharmaceuticals Company Details
13.3.2 Aequus Pharmaceuticals Business Overview and Its Total Revenue
13.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Introduction
13.3.4 Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020)
13.3.5 Aequus Pharmaceuticals Recent Development
13.4 Axim Biotechnologies
13.4.1 Axim Biotechnologies Company Details
13.4.2 Axim Biotechnologies Business Overview and Its Total Revenue
13.4.3 Axim Biotechnologies Cannabis-based Medicines Introduction
13.4.4 Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2015-2020)
13.4.5 Axim Biotechnologies Recent Development
13.5 Revive Therapeutics
13.5.1 Revive Therapeutics Company Details
13.5.2 Revive Therapeutics Business Overview and Its Total Revenue
13.5.3 Revive Therapeutics Cannabis-based Medicines Introduction
13.5.4 Revive Therapeutics Revenue in Cannabis-based Medicines Business (2015-2020)
13.5.5 Revive Therapeutics Recent Development
13.6 MGC Pharmaceuticals
13.6.1 MGC Pharmaceuticals Company Details
13.6.2 MGC Pharmaceuticals Business Overview and Its Total Revenue
13.6.3 MGC Pharmaceuticals Cannabis-based Medicines Introduction
13.6.4 MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020)
13.6.5 MGC Pharmaceuticals Recent Development
13.7 ECHO Pharmaceuticals
13.7.1 ECHO Pharmaceuticals Company Details
13.7.2 ECHO Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Introduction
13.7.4 ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020)
13.7.5 ECHO Pharmaceuticals Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Cannabis-based Medicines Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Cannabis-based Medicines Key Market Segments
Table 2. Key Players Covered: Ranking by Cannabis-based Medicines Revenue
Table 3. Ranking of Global Top Cannabis-based Medicines Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cannabis-based Medicines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CBD (Cannabidiol) Based
Table 6. Key Players of THC (Tetrahydrocannabinol) Based
Table 7. Key Players of Others
Table 8. Global Cannabis-based Medicines Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Cannabis-based Medicines Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Cannabis-based Medicines Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Cannabis-based Medicines Market Share by Regions (2015-2020)
Table 12. Global Cannabis-based Medicines Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Cannabis-based Medicines Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Cannabis-based Medicines Market Growth Strategy
Table 18. Main Points Interviewed from Key Cannabis-based Medicines Players
Table 19. Global Cannabis-based Medicines Revenue by Players (2015-2020) (Million US$)
Table 20. Global Cannabis-based Medicines Market Share by Players (2015-2020)
Table 21. Global Top Cannabis-based Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cannabis-based Medicines as of 2019)
Table 22. Global Cannabis-based Medicines by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cannabis-based Medicines Product Solution and Service
Table 25. Date of Enter into Cannabis-based Medicines Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 28. Global Cannabis-based Medicines Market Size Share by Type (2015-2020)
Table 29. Global Cannabis-based Medicines Revenue Market Share by Type (2021-2026)
Table 30. Global Cannabis-based Medicines Market Size Share by Application (2015-2020)
Table 31. Global Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 32. Global Cannabis-based Medicines Market Size Share by Application (2021-2026)
Table 33. North America Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 35. North America Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 36. North America Cannabis-based Medicines Market Share by Type (2015-2020)
Table 37. North America Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 38. North America Cannabis-based Medicines Market Share by Application (2015-2020)
Table 39. Europe Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 41. Europe Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Cannabis-based Medicines Market Share by Type (2015-2020)
Table 43. Europe Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Cannabis-based Medicines Market Share by Application (2015-2020)
Table 45. China Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 46. China Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 47. China Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 48. China Cannabis-based Medicines Market Share by Type (2015-2020)
Table 49. China Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 50. China Cannabis-based Medicines Market Share by Application (2015-2020)
Table 51. Japan Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 53. Japan Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Cannabis-based Medicines Market Share by Type (2015-2020)
Table 55. Japan Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Cannabis-based Medicines Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 59. Southeast Asia Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Cannabis-based Medicines Market Share by Type (2015-2020)
Table 61. Southeast Asia Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Cannabis-based Medicines Market Share by Application (2015-2020)
Table 63. India Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 64. India Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 65. India Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 66. India Cannabis-based Medicines Market Share by Type (2015-2020)
Table 67. India Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 68. India Cannabis-based Medicines Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 71. Central & South America Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Cannabis-based Medicines Market Share by Type (2015-2020)
Table 73. Central & South America Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Cannabis-based Medicines Market Share by Application (2015-2020)
Table 75. GW Pharmaceuticals plc Company Details
Table 76. GW Pharmaceuticals plc Business Overview
Table 77. GW Pharmaceuticals plc Product
Table 78. GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 79. GW Pharmaceuticals plc Recent Development
Table 80. INSYS Therapeutics Company Details
Table 81. INSYS Therapeutics Business Overview
Table 82. INSYS Therapeutics Product
Table 83. INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 84. INSYS Therapeutics Recent Development
Table 85. Aequus Pharmaceuticals Company Details
Table 86. Aequus Pharmaceuticals Business Overview
Table 87. Aequus Pharmaceuticals Product
Table 88. Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 89. Aequus Pharmaceuticals Recent Development
Table 90. Axim Biotechnologies Company Details
Table 91. Axim Biotechnologies Business Overview
Table 92. Axim Biotechnologies Product
Table 93. Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 94. Axim Biotechnologies Recent Development
Table 95. Revive Therapeutics Company Details
Table 96. Revive Therapeutics Business Overview
Table 97. Revive Therapeutics Product
Table 98. Revive Therapeutics Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 99. Revive Therapeutics Recent Development
Table 100. MGC Pharmaceuticals Company Details
Table 101. MGC Pharmaceuticals Business Overview
Table 102. MGC Pharmaceuticals Product
Table 103. MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 104. MGC Pharmaceuticals Recent Development
Table 105. ECHO Pharmaceuticals Company Details
Table 106. ECHO Pharmaceuticals Business Overview
Table 107. ECHO Pharmaceuticals Product
Table 108. ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 109. ECHO Pharmaceuticals Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cannabis-based Medicines Market Share by Type: 2020 VS 2026
Figure 2. CBD (Cannabidiol) Based Features
Figure 3. THC (Tetrahydrocannabinol) Based Features
Figure 4. Others Features
Figure 5. Global Cannabis-based Medicines Market Share by Application: 2020 VS 2026
Figure 6. Oral Solution Case Studies
Figure 7. Tablets Case Studies
Figure 8. Patches Case Studies
Figure 9. Others Case Studies
Figure 10. Cannabis-based Medicines Report Years Considered
Figure 11. Global Cannabis-based Medicines Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cannabis-based Medicines Market Share by Regions: 2020 VS 2026
Figure 13. Global Cannabis-based Medicines Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cannabis-based Medicines Market Share by Players in 2019
Figure 16. Global Top Cannabis-based Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cannabis-based Medicines as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cannabis-based Medicines Revenue in 2019
Figure 18. North America Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. GW Pharmaceuticals plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. GW Pharmaceuticals plc Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 27. INSYS Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. INSYS Therapeutics Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 29. Aequus Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Aequus Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 31. Axim Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Axim Biotechnologies Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 33. Revive Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Revive Therapeutics Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 35. MGC Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. MGC Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 37. ECHO Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. ECHO Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Keyplayers in Global Cannabis-based Medicines Market Size, Status and Forecast 2020-2026
GW Pharmaceuticals plcINSYS Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals